LabGenius
Machine-learning and automation platform for discovering therapeutic antibodies for biotechnology and pharmaceutical companies
Highlights
- Hiring2 open roles
- New on EvolcAdded 2026-10-28
- Remote-friendly1 of 2 open roles remote or hybrid
About LabGenius
LabGenius Therapeutics develops EVA, an automated discovery platform that identifies and co-optimises complex therapeutic antibodies using machine learning and protein engineering. Its internal pipeline focuses on selectivity-enhanced antibodies for solid tumours.
The company works with biotechnology and pharmaceutical companies seeking to enhance their antibody discovery pipelines, including through research partnerships. Its platform is modality- and format-agnostic.
LabGenius was founded during CEO James Field’s PhD studies at Imperial College London. It is hiring for automation science and data science roles in London.
Product: EVA, an automated machine-learning platform for discovering and co-optimising therapeutic antibodies, alongside an internal antibody therapeutics pipeline.
Jobs at LabGenius (2)
LabGenius is hiring for 2 roles, mostly in data & AI, based in London.
Data Scientist
New on EvolcRemote-friendlyAutomation Scientist
New on EvolcRemote-friendly
Companies hiring like LabGenius
Leadership
- James Field · Chief Executive OfficerSource: company website
- Edward de Moraville · VP, FinanceSource: company website
- Winston Haynes · VP, Computational Sciences and EngineeringSource: company website
- Lucy Shaw · Head of CommunicationsSource: company website
- Michael Mullin · Head of Antibody EngineeringSource: company website
More biotech & pharma companies
Lario Therapeutics
Develops disease-modifying precision medicines for severe epileptic disorders and Parkinson's disease, startingYoung companyNew on EvolcLevicept
Develops a non-opioid biologic treatment for osteoarthritis pain for patients with painful joint diseaseNew on EvolcLGC Group
Reference materials, diagnostic quality controls and analytical standards for labs and life-science companiesNew on EvolcLibero Pharma
Develops transdermal naltrexone patches for patients with addiction, fibromyalgia and Crohn’s diseaseNew on EvolcLightcast Discovery
Single-cell functional screening platform for antibody and drug discovery teams in biotech and pharma researchNew on EvolcLiminal Biosciences
Develops small-molecule therapeutics for metabolic, inflammatory and fibrotic diseases through GPCR pathwaysNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Complianz
- Elementor
- Fastly
- Google Analytics 4
- Google reCAPTCHA
- Teamtailor
- WordPress
- jQuery
- nginx
